16 February 2009 SUBMISSION BY THE SOUTH AFRICAN MEDICAL DEVICE INDUSTRY ASSOCIATION (SAMED)

Size: px
Start display at page:

Download "16 February 2009 SUBMISSION BY THE SOUTH AFRICAN MEDICAL DEVICE INDUSTRY ASSOCIATION (SAMED)"

Transcription

1 16 February 2009 SUBMISSION BY THE SOUTH AFRICAN MEDICAL DEVICE INDUSTRY ASSOCIATION (SAMED) To The Registrar, Health Professions Council of South Africa, P.O. Box 205, Pretoria 0001 (for the attention of the Senior Manager: Professional Boards) on 1. Booklet 7: GUIDELINES ON OVERSERVICING, PERVERSE INCENTIVES AND RELATED MATTERS (SECOND EDITION) 2. Booklet 2: ETHICAL AND PROFESSIONAL RULES OF THE HEALTH PROFESSIONS COUNCIL OF SOUTH AFRICA AS PROMULGATED IN GOVERNMENT GAZETTE R717/2006, (SECOND EDITION) SAMED Reg nr. 2002/005232/08 Tel: Fax: PO Box , Benmore, 2010, South Africa 52 Thembi Place, Calderwood Road, Lonehill Directors: T.M. Vogt (Chief Operating Officer), M.J.F. Howe-Ely (SAMED Chairman), R.D. Crawford (SAMED Vice Chairman), M. Brand, M.G. Burgess, L.J. Curran, A.H. Denoon, W. Flowers, G.R. John, R.A. Marconi, R.J. Millar,, M. Pearce, G. Stier, G.D. Young (SAMED Treasurer) Page 1

2 Index Page 1. Introduction 3 2. Comment on Booklet Comment on Booklet 2 15 Page 2

3 1. Introduction The South African Medical Device Industry Association (SAMED) is a voluntary organisation that represents the interests of the Medical Device Industry in South Africa. SAMED supports the initiative taken by the Registrar of the Health Professions Council of South Africa with regard to a call for comment by stakeholders on the various guidelines for good practice in the healthcare professions. SAMED s comments have been cross referenced to the clauses as numbered in the two booklets in question. SAMED respectfully requests that the recommendations proposed in this submission be given due consideration, and requests that SAMED be afforded the opportunity to verbally present to the HPCSA on the contents of this submission. Yours sincerely Tanya Vogt Chief Operating Officer SAMED Tel Fax tanya@samed.org.za Page 3

4 2. Comments on Booklet It should further be noted that in terms of these guidelines, it is an offence either to offer a perverse incentive or to accept one. 2. Defining of Concepts It should further be noted that some of these definitions have been based on those in certain Acts of Parliament - in particular the definitions contained in the draft of the South African Medicines and Medical Devices Regulatory Authority Act, (Act No. 132 of 1998). 2.5 Health care professional means any person registered in terms of the applicable Act which governs the functioning of any of the Councils that form part of the Forum of Statutory Health Councils. This includes persons registered by the Health Professions Council of South Africa. The term also includes registered student health care practitioners. The wording suggests this only applies to healthcare professionals. SAMED suggests this clause define from who and to who i.e. it should be extended to: to the trade and from the trade (medical device suppliers) Act No. 132 of 1998 never came into being. It should be changed to read Act 101 as amended. SAMED suggests aligning 2.5 with 2.6 i.e. definition of health care professional to include health care practitioner. It is also suggested that only health care professional be used subsequently in the document. 2.6 Health care practitioner means any person registered with the HPCSA. 2.9 Improper financial gain or other valuable consideration means money, or any other form of compensation, payment, reward or benefit which is not legally due or which is given on the understanding, whether express, implied or tacit, that the recipient will engage or refrain from engaging in certain behaviour in a manner which is either: Does this include the trade? SAMED suggests this clause must state from any party Contrary to ethical or professional rules and/or Which ethical or professional rules are implied here? SAMED suggests that the implied rules be listed Which, in the opinion of the HPCSA, may adversely affect SAMED is concerned that basing a decision on an opinion is providing the Page 4

5 the interests of a patient or group of patients, HPCSA too much power e.g. the HPCSA might rule that an otherwise illegal action is acceptable i.e. what informs such an opinion. SAMED suggests the following rewording:.affect the interests, both medical or other, of a patient or group of patients, And adding an additional clause i.e Irrespective of patient outcome HCP may not receive financial gain of any type Medical device means any instrument, appliance, material, machine, apparatus, implant or diagnostic reagent or any other article, whether used alone or in combination, including software necessary for its proper application used for or purporting to be suitable for use or manufactured or sold for use in or on a human or animal body: In the diagnosis, prevention, monitoring, treatment or alleviation of disease; or In diagnosis, monitoring, treatment, alleviation of or compensation for an injury or handicap; or In investigation, replacement or modification of the anatomy or of a physiological process; or In the diagnosis of pregnancy, or the control of conception or termination of pregnancy, And which does not achieve its principal intended action in or on the human body by chemical, pharmacological, immunological or metabolic means, but which may be assisted in its function by such means: and device has the same meaning. SAMED suggests the definition of a medical device be aligned with the Medicines and Related Substances Bill, as amended i.e. "..any instrument, apparatus, implement, machine, appliance, implant, in vitro reagent or calibrator, software, material or other similar or related article: (a) intended by the manufacturer to be used, alone or in combination, for human beings for one or more of the specific purpose(s) of: and Diagnosis, prevention, monitoring, treatment or alleviation of disease Diagnosis, monitoring, treatment, alleviation of or compensation for an injury, Investigation, replacement, modification, or support of the anatomy or of a physiological process Support or sustaining life Control of conception Disinfection of medical devices Providing for information for medical or diagnostic purposes by means of in vitro examination of specimens derived from the human body (b) which does not achieve its primary intended action in or on the human body by pharmacological, immunological or metabolic means, but which may be assisted in its intended function by such means". Page 5

6 2.14 Overservicing means the supply, provision, administration, use or prescription of any treatment or care (including diagnostic and other testing, medicines and medical devices) which is medically and clinically not indicated, unnecessary or inappropriate under the circumstances or which is not in accordance with the recognised treatment protocols and procedures, without due regard to both the financial and health interests of the patient Promote means any action taken by a person or body or allowed to be taken by such person or body to further or to encourage the preferential use of any health establishment or orthodox medicine, complementary medicine, veterinary medicine, medical device or scheduled substance or health related product or health related service or to further or to encourage the preferential sale of any such product or service for the purpose of financial gain or other valuable consideration: This definition does, however, not prohibit the practice of those professions where, in terms of their scopes of practice, it is appropriate to sell such product or service at market related prices. SAMED suggests the following rewording (see underlined text): Overservicing means the supply, rental, provision, administration, use or prescription of any treatment or care (including diagnostic and other testing, medicines and medical devices) which is medically and clinically not indicated, unnecessary or inappropriate under the circumstances or which is not in accordance with the recognised treatment protocols and procedures, without due regard to both the financial and health interests of the patient. And the addition of the following clause after overservicing i.e Underservicing e.g. where a surgeon is forced by medical aids to use cheaper products more often or where a doctor is induced by medical aids to comply with medical aid requirements e.g. the medical aid compels the HCP to work at a particular hospital or use a medical aid preferred product and in return the surgeon is given a certain top fee i.e. paying surgeons more to use the product or work in particular areas. SAMED questions the potential for perversity here. Ultimately medical aids make more money because they are able to reduce their benefits, thus reducing the cost of medical aid and getting more members SAMED suggests the addition of the following text (see underlined): This definition does, however, not prohibit the practice of those professions where, in terms of their scopes of practice, it is appropriate to sell such product or service at market related prices, provided application has been made to the HPCSA and special permission given. SAMED assumes this clause relates specifically to dispensing doctors. However this could provide a loophole for doctors to sell devices. It is requested that the HPCSA consider the difference between dispensing and commercialising a product. E.g. surgeon buys product e.g. hip implant, artificial breast, bariatric surgery and then sells to patient Scheduled substance means any medicine prescribed under section 31 of the South African Medicines and Remove reference to Act 132. Act No. 132 of 1998 has not yet been brought into effect and at present the Medicines and Related Substances Control Act (Act Page 6

7 Medical Devices Regulatory Authority Act (Act No. 132 of 1998). No. 101 of 1965 as amended) is still in force Spouse means a person s partner in marriage and includes for the purpose of this policy statement, a person with whom another person lives as if they were married or with whom one habitually cohabits Trade means an act or instance of buying, selling or purchasing goods and services for the purpose of financial gain or other valuable consideration. SAMED suggests the following additional clause i.e. potential means of doing business should not only be limited to spouses but also to: immediate family members, or a trust linked to a trading company from which the practitioner and his or her immediate family members, spouse or life partner may benefit. HCP s shall not, hold any shares or be part of any business which is not a listed entity or participate in the manufacture for commercial purposes, or in the sale, advertising or promotion of any medicine or medical device or in any activity which amounts to trading in medicine or medical devices to the public or keeping an open shop or pharmacy, and excludes: (a) situations where the practitioner is by law allowed to sell and dispense devices and/or medicine, subject to the provisions of rule 23(5); (b) situations where such family member, spouse or life partner is bona fide employed in the device industry and there is no perverse relationship between the industry player and the practitioner through the employment of such family member, spouse or life partner Trade means an act or instance of buying, selling or purchasing goods and services from any source for the purpose of financial gain or other valuable consideration. Page 7

8 2 OVERSERVICING, PERVERSE INCENTIVES AND RELATED MATTERS The following acts or omissions are not permissible for any health care practitioner, nor is it ethical for any health related body to encourage health care professionals to engage in any of them: The following acts or omissions are not permissible for any health care practitioner / health care professional, nor is it ethical or legal (where governed by legislation) for any health related body to encourage health care professionals to engage in any of them: SAMED suggests the incorporation of a definition of health related body i.e. any body or organisation whose business is health related matters. This includes, but is not limited to: Medical Aids, Medical Administrators and Funders, Trade, Trade Associations, MCO s, Consultants etc, 3.1 OVERSERVICING Health care practitioners shall not: Health care practitioners / Health care professionals shall not: Refer a patient to another health care practitioner / health care professional for a service or a procedure that is neither indicated nor scientific or has been shown to be ineffective, harmful or inappropriate through evidence-based review. [Note: Over servicing by ordering or providing more tests, procedures or care than is strictly necessary, is common problem in modern medicine. Health care practitioners / health care professionals must therefore not engage in any act that would constitute over servicing of patients] Refer a patient to another health care practitioner / health care professional for a service or a procedure that is neither indicated nor scientific or has been shown to be ineffective, harmful or inappropriate through evidencebased review. [Note: Over servicing by ordering or providing more tests, procedures or care than is strictly necessary, is common problem in modern medicine. Health care practitioners / health care professionals must therefore not engage in any act that would constitute over servicing of patients]. 3.2 MANUFACTURING Health care practitioners shall not manufacture or participate in the manufacture for commercial purposes or trade, of orthodox medicine, complementary medicine, veterinary medicine, a medical device or a scheduled substance or a health related Health care practitioners / health care professionals shall not manufacture, distribute or participate in the manufacture or distribution, for commercial purposes or trade, of orthodox medicine, complementary medicine, veterinary medicine, a medical device or a scheduled substance or a health related product, except where such medicine or device or substance or product forms an Page 8

9 product, except where such medicine or device or substance or product forms an integral part of the normal scope of practice of the health care practitioner concerned or where explicit permission was granted to a health care professional by the HPCSA to manufacture or to participate in the manufacture of such medicine, device, substance or product. 3.3 ADVERTISING Health care practitioners shall not advertise or endorse or encourage the use of any health establishment or orthodox medicine, complementary medicine, veterinary medicine, medical device or scheduled substance or health related product or health related service in a manner that unfairly promotes the practice of a particular health care practitioner or a health care facility for the purpose of improper financial gain or other valuable consideration. integral part of the normal scope of practice of the health care practitioner concerned or where explicit permission was granted to a health care professional by the HPCSA to manufacture, distribute or to participate in the manufacture or distribution of such medicine, device, substance or product. SAMED suggests this section be reworded in such a way as to ensure the prevention of possible commercial gain. i.e. HCP s should be prohibited from selling a device they may have manufactured or invented. They should only be able to obtain royalties on the device and may not use the device exclusively (i.e. only that and no other device) on their patients. Health care practitioners / Health care professionals shall not advertise or endorse or encourage the use of any health establishment or orthodox medicine, complementary medicine, veterinary medicine, medical device or scheduled substance or health related product or health related service in a manner that unfairly promotes the practice of a particular health care practitioner or a health care facility for the purpose of improper financial gain or other valuable consideration. Page 9

10 3.4 PREFERENTIAL USAGE OR PRESCRIPTIONS Health care practitioners shall not engage in or advocate the preferential use of any health establishment or medical device or health related service or prescribe any orthodox medicine, complementary medicine, veterinary medicine or scheduled substance, if any improper financial gain or other valuable consideration is derived from such preferential usage or prescription or the advocacy of preferential usage by the health care professional - unless entitled by law. 3.6 TECHNOLOGICAL EQUIPMENT Health care practitioners shall only own and use technological equipment if it forms an integral part of their scope of practice and on condition that the health care practitioner concerned has received appropriate training in using and managing such equipment Health care practitioners / health care professionals shall not over-use equipment for procedures, tests and other applications that are not indicated, scientific or based on evidence. This constitutes overservicing and is prohibited Health care professionals shall not use technological equipment, health care products or devices for profiteering and must refrain from charging patients fees for the use of such products or devices that are not market related. Health care practitioners / Health care professionals shall not engage in or advocate the preferential use of any health establishment or medical device or health related service or prescribe any orthodox medicine, complementary medicine, veterinary medicine or scheduled substance, if any improper financial gain or other valuable consideration is derived from such preferential usage or prescription or the advocacy of preferential usage by the health care practitioner / health care professional - unless entitled by law Health care practitioners / health care professionals shall only own and use technological equipment if it forms an integral part of their scope of practice and on condition that the health care practitioner concerned has received appropriate training in using and managing such equipment Health care practitioners / health care professionals shall not over-use equipment for procedures, tests and other applications that are not indicated, scientific or based on evidence. This constitutes overservicing and is prohibited Health care practitioners / health care professionals shall not use technological equipment, health care products or devices for profiteering and must refrain from charging patients fees for the use of such products or devices that are not market related. 3.7 SHARE HOLDING It is unethical for a health care practitioner to refer patients to a facility or for a procedure in which such practitioner has a financial interest. All health care practitioners have an obligation to avoid this conflict of interest, and to protect the professional relationship and It is unethical for a health care practitioner / health care professional to refer patients to a facility or for a procedure in which such practitioner has a financial interest. All health care practitioners / health care professional have an obligation to avoid this conflict of interest, and to protect the professional relationship and the long term interests of the Page 10

11 the long term interests of the health care professions. health care professions In acquiring shares a health care practitioner shall not: In acquiring shares a health care practitioner / health care professional shall not: SAMED suggests the addition of a clause to this section, the intention being to prevent practitioners from trading in devices under the guise of trusts, closed corporations or family owned companies i.e A health care practitioner / professional and his or her immediate family members, spouse or life partner, or a trust linked to a trading company from which the practitioner / professional and his or her immediate family members, spouse or life partner may benefit, shall not, hold any shares or be part of any business which is not a listed entity, participate in the manufacture or distribution for commercial purposes, or in the sale, advertising or promotion of any medicine or medical device or in any activity which amounts to trading in medicines or medical devices to the public or keeping an open shop or pharmacy, and excludes: (a) situations where the practitioner / professional is by law allowed to sell and dispense devices and/or medicine (b) situations where such family member, spouse or life partner is bona fide employed in the device industry and there is no perverse relationship between the industry player and the practitioner through the employment of such family member, spouse or life partner. 3.9 COMMISSION Accepting commission Health care practitioners shall not accept commission or any financial gain or other valuable consideration from any person or body or service in return for the purchase, sale or supply of any goods, substances or materials used by the health care SAMED suggests the following additions and amendments: Accepting commission Health care practitioners / health care professionals shall not accept commission or any financial gain or other valuable consideration from any health related body (which will be defined under definitions section to include medical device and IVD establishments) person or body or Page 11

12 professional in his or her practice. service in return for the purchase, sale or supply of any medical devices, goods, substances or materials used by the health care practitioner / professional in his or her practice Paying commission Health care practitioners shall not pay commission or render any financial gain or other valuable consideration to any person for recommending patients. SAMED suggests the following addition, see underlined text: Health care practitioners / health care professionals shall not pay commission or render any financial gain or other valuable consideration to any person for recommending patients CONTINUING PROFESSIONAL DEVELOPMENT Health care provider organisations The decision on content and choice of continuing professional development activities, as well as funding arrangements lies ultimately with the health care provider organisations such as professional associations, their branches and groups who should not be in a position of conflict of interest by virtue of any relationship with the funding body. The organisers may acknowledge financial or other aid received, but should not identify any specific products. Generic names of products should be used rather than trade names in the course of continuing professional development activities Funding Funds for continuing professional development activities should preferably be in the form of an educational grant payable to the health care provider organisation arranging the activity. SAMED seeks clarity on who is referred to here? I.e. a clear definition of a healthcare provider organisation is requested. SAMED suggests the following additions, see underlined text: Funds for continuing professional development activities should preferably be in the form of an educational grant payable to the health care provider organisation arranging the activity or via the healthcare organisation to whom the practitioner belongs. In the event that a HCP needs to be reimbursed directly for costs incurred, such Page 12

13 reimbursement shall be supported by original documentation e.g. invoices, receipts etc Travel, lodging and other expenses with regard to the attendance of CPD events No travel or lodging costs or other expenses should be paid by the industry for individual health care practitioners to attend a CPD event. Scholarships, grants or other special funding, to permit students and other deserving health care professionals to attend CPD activities are permissible, provided the funds are paid to the organisers for disbursements. The organisers may extend reasonable honoraria and imbursement for travel, lodging and meal expenses to speakers. The principal event should at all times centre around education and not around meals, entertainment or other hospitality, the cost of which should not exceed that level at which the recipients might reasonably be expected to incur for themselves under similar circumstances. SAMED seeks clarity that this clause applies only to local events and suggests the following amendments / additions: No travel or lodging costs or other expenses should be paid by the industry for individual health care practitioners to attend a local CPD event. Scholarships, grants or other special funding, to permit students and other deserving health care professionals to attend CPD activities are permissible, provided the funds are paid to the organisers for disbursements. (What if the organisers are the company arranging the workshop? Will this be acceptable?) The organisers may extend reasonable honoraria and imbursement for travel, lodging and meal expenses to speakers. The principal event should at all times centre around education and not around meals, entertainment or other hospitality, the cost of which should not exceed that level at which the recipients might reasonably be expected to incur for themselves under similar circumstances. SAMED questions the realism of this clause i.e. it is doubtful that doctors and / or nurses, other than speakers, actually attend if their travel etc is not paid for. For state employees payment for sponsorship shall be paid only via the service providers i.e. airline, hotel, congress organiser Distinction between education, training and product promotion SAMED suggests that this clause should only apply to local events and that medical device companies should be allowed to pay for international travel and lodging for doctors to attend product launches. The reasoning here is that many devices are very large equipment and some cannot be moved. It may not warrant the supplier bringing it all the way to SA if they are not assured of selling it. For example: radiology equipment or a digital theatre. Page 13

14 4. Accountability Mention is made of an annexure, but this appears to be missing. Health care practitioners who decide not to follow the guidance in this Booklet (including the Annexure), must be prepared to explain and justify their actions and decisions to patients and their families, their colleagues and, if necessary, to the courts and the HPCSA. Ethical guidelines for good practice in the health care professions The following Booklets are separately available: Booklet 7: General ethical guidelines for health researchers SAMED is unsure whether this title is correct and suggests that it should read: Booklet 7: Guidelines on overservicing, perverse incentives and related matters (second edition) Page 14

15 3. Comments / Suggested Amendments to Booklet 2 SAMED suggests the addition of the following clause, after clause 23 and before clause 24 pertaining to medical devices 24. Medical Devices 24. (1) A practitioner shall not participate in the manufacture for commercial purposes, or in the sale, advertising or promotion of any medical device or in any other activity which amounts to trading in medical devices. (2) A practitioner shall not engage in or advocate the preferential use or prescription of any medical device, if any valuable consideration is derived from such preferential use or prescription. (3) The provisions of subrules (1) and (2) shall not prohibit a practitioner from - (a) (b) (c) (d) owning shares in a listed company; manufacturing or marketing medical devices whilst employed by a medical device concern; whilst employed by a medical device concern in any particular capacity, performing such duties as are normally in accordance with such employment; or dispensing in terms of a licence issued in terms of the Medicines and Related Substances Act, (4) A practitioner referred to in subrule (3) shall display a conspicuous notice in his or her waiting room and also, if appropriate, verbally inform his or her patient about the fact that he or she - (a) (b) owns shares in a listed public company which manufactures or markets the medical devices prescribed to such patient; or is in the employ of the medical device concern which manufactures such medical device(s). (5) A practitioner may prescribe medical devices: Provided that such practitioner has ascertained the diagnosis of the patient concerned through a personal examination of such patient or by virtue of a report by another practitioner under whose treatment such patient is or has been. (6) In the case of a patient with a chronic disease the provision of subrule (5) shall not apply. Page 15

Industry s Perspective on the Status of Medical Device Regulations. FUNDISA Workshop 09 & 10 Oct Anele Vutha SAMED Regulatory Committee

Industry s Perspective on the Status of Medical Device Regulations. FUNDISA Workshop 09 & 10 Oct Anele Vutha SAMED Regulatory Committee Industry s Perspective on the Status of Medical Device Regulations FUNDISA Workshop 09 & 10 Oct 2014 Anele Vutha SAMED Regulatory Committee Today s Topics: 1. Medical Device Definition - Differences 2.

More information

Guide to Professional Conduct and Ethics for Registered Medical Practitioners. Relationships between doctors and industry Frequently Asked Questions

Guide to Professional Conduct and Ethics for Registered Medical Practitioners. Relationships between doctors and industry Frequently Asked Questions Guide to Professional Conduct and Ethics for Registered Medical Practitioners Relationships between doctors and industry Frequently Asked Questions Partnership Practice Performance Relationships between

More information

(English text signed by the State President) as amended by

(English text signed by the State President) as amended by TOBACCO PRODUCTS CONTROL ACT 83 OF 1993 [ASSENTED TO 23 JUNE 1993] [DATE OF COMMENCEMENT: 1 FEBRUARY 1994] (English text signed by the State President) as amended by General Law Fifth Amendment Act 157

More information

Government Gazette REPUBLIC OF SOUTH AFRICA

Government Gazette REPUBLIC OF SOUTH AFRICA Government Gazette REPUBLIC OF SOUTH AFRICA Vol. 523 Cape Town 9 January 2009 No. 31790 THE PRESIDENCY No. 23 9 January 2009 It is hereby notified that the President has assented to the following Act,

More information

These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017.

These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017. Rules of Membership 1. Introduction These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017. The previously published

More information

Draft Regulation R-013: Spousal Exemption to Sexual Abuse Provisions and Draft Standard of Practice S-032: Providing Chiropractic Care to a Spouse

Draft Regulation R-013: Spousal Exemption to Sexual Abuse Provisions and Draft Standard of Practice S-032: Providing Chiropractic Care to a Spouse ONTARIO CHIROPRACTIC ASSOCIATION ASSOCIATION CHIROPRATIQUE DE L ONTARIO March 26, 2015 Joel Friedman, Director, Policy and Research College of Chiropractors of Ontario 130 Bloor St. West, Suite 902 Toronto,

More information

Novo Nordisk Pharma AG Methodology Note - reporting year 2016 ( Methodology )

Novo Nordisk Pharma AG Methodology Note - reporting year 2016 ( Methodology ) Novo Nordisk Pharma AG Methodology Note - reporting year 2016 ( Methodology ) Table of contents Preamble... 0 1. General Summary... 1 2. Terminology and Definitions... 2 3. Change log... 8 Preamble Novo

More information

on the advertising of medicinal products for human use

on the advertising of medicinal products for human use 30. 4. 92 Official Journal of the European Communities No L 113 / 13 COUNCIL DIRECTIVE 92/28/EEC of 31 March 1992 on the advertising of medicinal products for human use THE COUNCIL OF THE EUROPEAN COMMUNITIES,

More information

DRAFT FOR CONSULTATION

DRAFT FOR CONSULTATION DRAFT FOR CONSULTATION Member s Bill Explanatory note General policy statement Smoking rates and tobacco consumption have declined in recent decades. However, 4 500 to 5 000 New Zealanders still die prematurely

More information

making a referral for breast imaging Standard Operating Procedure

making a referral for breast imaging Standard Operating Procedure Document Control Title Reporting Radiographer Author Directorate Surgery Date Version Issued 0.1 May 2016 Status Draft Author s job title Reporting Radiographer Department Breast Imaging Comment / Changes

More information

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: CARD/MAIL/PRE-APPROVAL/PREFERRED The Prescription Drug Coverage under this Rider [replaces] [supplements] the Prescription

More information

RFQ:-HPCSA 03/2017 REQUEST FOR QUOTATION FOR OCCUPATIONAL HEALTH SERVICE ON BEHALF OF THE HEALTH PROFESSIONS COUNCIL OF SOUTH AFRICA

RFQ:-HPCSA 03/2017 REQUEST FOR QUOTATION FOR OCCUPATIONAL HEALTH SERVICE ON BEHALF OF THE HEALTH PROFESSIONS COUNCIL OF SOUTH AFRICA RFQ:-HPCSA 03/2017 REQUEST FOR QUOTATION FOR OCCUPATIONAL HEALTH SERVICE ON BEHALF OF THE HEALTH PROFESSIONS COUNCIL OF SOUTH AFRICA Situated at: 553 Madiba Street, Arcadia, Pretoria Deadline for submission:

More information

STATUTORY INSTRUMENTS. S.I. No. 531 of 2018 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) (NO. 2) REGULATIONS 2018

STATUTORY INSTRUMENTS. S.I. No. 531 of 2018 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) (NO. 2) REGULATIONS 2018 STATUTORY INSTRUMENTS. S.I. No. 531 of 2018 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) (NO. 2) REGULATIONS 2018 2 [531] S.I. No. 531 of 2018 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) (NO. 2) REGULATIONS

More information

Medical Devices. SOUTH AFRICA Bowman Gilfillan

Medical Devices. SOUTH AFRICA Bowman Gilfillan Medical Devices SOUTH AFRICA Bowman Gilfillan CONTACT INFORMATION Llewellyn Parker Bowman Gilfillan PO Box 785812, Sandton, 2146 South Africa +27 11 669 9635 l.parker@bowman.co.za www.bowman.co.za 1. Definition

More information

Guidance for Industry

Guidance for Industry MEDICAL DEVICES SECTOR Guidance for Industry Format and Content of Proposed Bundling/Grouping Criteria for Medical Devices DRAFT GUIDANCE This guidance document is being distributed for comment purposes

More information

Presentation to Parliamentary Portfolio Committee on Health

Presentation to Parliamentary Portfolio Committee on Health Presentation to Parliamentary Portfolio Committee on Health Bill 6 of 2014 Medicines and Related Substances Amendment Bill Presented by: Anele Vutha South African Medical Device Industry Association 29

More information

HOW TO LodgE a complaint against a

HOW TO LodgE a complaint against a HOW TO LodgE a complaint against a healthcare practitioner Protecting the public and guiding the professions Good health is your right All people have the right to good health and quality healthcare. This

More information

General Terms and Conditions

General Terms and Conditions General Terms and Conditions Revision history (November 2007) Date issued Replaced pages Effective date 11/07 ii, iii, 2, 4 11/07 11/06 all pages 11/06 01/06 all pages 01/06 02/05 ii, iii, 4, 7 8 02/05

More information

THE RESPONSIBLE PHARMACIST REGULATIONS

THE RESPONSIBLE PHARMACIST REGULATIONS THE RESPONSIBLE PHARMACIST REGULATIONS A SUMMARY OF THE RESPONSES TO PUBLIC CONSULTATION ON PROPOSALS FOR THE CONTENT OF THE REGULATIONS DH INFORMATION READER BOX Policy HR / Workforce Management Planning

More information

ENROLMENT FORM. Title: First Name: Surname: Postal Address: Postcode: Emergency Contact: Relationship: Phone: What is your main fitness goal?

ENROLMENT FORM. Title: First Name: Surname: Postal Address: Postcode:   Emergency Contact: Relationship: Phone: What is your main fitness goal? ENROLMENT FORM Personal Information Title: First Name: Surname: Date of Birth: Sex: Female Male Postal Address: Postcode: Phone: Home: Work: Mobile: Email: Preferred method of contact: Letter Phone Email

More information

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH 11 MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH Background The rules in this section are designed to ensure that advertisements that include health claims (please see Section 13 for health claims

More information

Exhibit 2 RFQ Engagement Letter

Exhibit 2 RFQ Engagement Letter Exhibit 2 RFQ 17-25 Engagement Letter The attached includes the 6 page proposed engagement letter to be used by HCC. ENGAGEMENT LETTER Dear: [Lead Counsel/Partner] We are pleased to inform you that your

More information

B.C. Cannabis PRIVATE RETAIL LICENSING GUIDE Applications and Operations

B.C. Cannabis PRIVATE RETAIL LICENSING GUIDE Applications and Operations B.C. Cannabis PRIVATE RETAIL LICENSING GUIDE Applications and Operations Copyright February 2018, Province of British Columbia. All rights reserved. This material is owned by the Government of British

More information

HRS Group UK Drug and Alcohol Policy

HRS Group UK Drug and Alcohol Policy HRS Group UK Drug and Alcohol Policy 1.0 Introduction The HRS Group UK Policy on Alcohol and Drugs is a fundamental part of the Company s strategy to safeguard the health, safety and welfare of all its

More information

Medical gap arrangements - practitioner application

Medical gap arrangements - practitioner application Medical gap arrangements - practitioner application For services provided in a licensed private hospital or day hospital facility (Private Hospital) only. Please complete this form to apply for participation

More information

The Role of the Responsible Pharmacist (RP)

The Role of the Responsible Pharmacist (RP) The Role of the Responsible Pharmacist (RP) Pharmaceutical industry perspective Vuyo Mokoena: Senior Manager: Monitoring, Compliance and Professional Conduct (MCPC) Overview Background Legislative provision

More information

Medical Devices. UKRAINE Magisters

Medical Devices. UKRAINE Magisters Medical Devices UKRAINE Magisters CONTACT INFORMATION Oleg Boichuk, Senior Associate Oleksandr Liulkov, Associate Magisters 38 Volodymyrska St., Kyiv, Ukraine +38044 492 82 82 www.magisters.com 1. Definition

More information

Health (Tobacco, Nicotine etc. and Care) (Scotland) Act 2016

Health (Tobacco, Nicotine etc. and Care) (Scotland) Act 2016 Health (Tobacco, Nicotine etc. and Care) (Scotland) Act 2016 2016 asp 14 Explanatory Notes have been produced to assist in the understanding of this Act and are available separately 6.00 Health (Tobacco,

More information

The Society welcomes the opportunity to respond the Department of Health s consultation on generic substitution.

The Society welcomes the opportunity to respond the Department of Health s consultation on generic substitution. Lindsey Gilpin Chairman of the English Pharmacy Board Telephone: 020 7572 2519 Fax: 0207 572 2501 e-mail: howard.duff@rpsgb.org 25 th March 2010 Dear Sir/Madam, Consultation on the proposals to implement

More information

Maintaining Appropriate Boundaries and Preventing Sexual Abuse

Maintaining Appropriate Boundaries and Preventing Sexual Abuse POLICY STATEMENT #4-08 Maintaining Appropriate Boundaries and Preventing Sexual Abuse APPROVED BY COUNCIL: PUBLICATION DATE: REVIEWED AND UPDATED: KEY WORDS: September 2008 December 2008 June 2017 Sexual

More information

Review of Medicines Act 1968: informal consultation on issues relating to the PLR regime and homeopathy

Review of Medicines Act 1968: informal consultation on issues relating to the PLR regime and homeopathy Review of Medicines Act 1968: informal consultation on issues relating to the PLR regime and homeopathy Introduction 1. The consolidation and review of the UK medicines legislation (including the Medicines

More information

PHYSIOTHERAPY ACT AUTHORIZATION REGULATIONS

PHYSIOTHERAPY ACT AUTHORIZATION REGULATIONS c t PHYSIOTHERAPY ACT AUTHORIZATION REGULATIONS PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this regulation, current to July 11, 2009. It is intended

More information

Ethical Practice Guidelines on Financial Incentives from Hearing Instrument Manufacturers

Ethical Practice Guidelines on Financial Incentives from Hearing Instrument Manufacturers Ethical Practice Guidelines on Financial Incentives from Hearing Instrument Manufacturers Ethical Guidelines The following general guidelines have been accepted by the Board of Directors of the Academy

More information

Independent Assurance Statement by Bureau Veritas

Independent Assurance Statement by Bureau Veritas Nestlé S.A. Independent Assurance of Compliance with the Nestlé Policy and Instructions for Implementation of the WHO International Code of Marketing of Breastmilk Substitutes in Pakistan (August 2015)

More information

G O V E R N M E N T N O T I C E S G O E W E R M E N T S K E N N I S G E W I N G S

G O V E R N M E N T N O T I C E S G O E W E R M E N T S K E N N I S G E W I N G S STAATSKOERANT, 29 SEPTEMBER 2000 No. 21610 p.5 G O V E R N M E N T N O T I C E S G O E W E R M E N T S K E N N I S G E W I N G S DEPARTMENT OF HEALTH DEPARTMENT VAN GESONDHEID No. R. 974 29 September 2000

More information

(City, State, Zip Code)

(City, State, Zip Code) This Partner Agency Agreement, dated this day of, 2015, is between COMMUNITY FOOD SHARE, INC. (CFS), whose address is 650 South Taylor Avenue, Louisville, CO 80027, and (Partner Agency) whose address is

More information

NO SMOKING POLICY. Organisational

NO SMOKING POLICY. Organisational NO SMOKING POLICY Policy Title State previous title where relevant. State if Policy New or Revised Policy Strand Org, HR, Clinical, H&S, Infection Control, Finance For clinical policies only - state index

More information

MIAMI CHILDREN S HOSPITAL POLICY AND PROCEDURE

MIAMI CHILDREN S HOSPITAL POLICY AND PROCEDURE ISSUED BY: Research PAGE: 1 of 6 REPLACES POLICY DATED: EFFECTIVE DATE: 08/09/2012 DISTRIBUTION: Departmentwide APPROVED BY: Andrews, April (SVP/CECO), BOD Audit and Compliance Committee, Perdomo, Jose

More information

1. Introduction. 2. Role of PSI as Pharmacy Regulator

1. Introduction. 2. Role of PSI as Pharmacy Regulator 1. Introduction 1.1. I would like to begin by thanking the Committee for inviting the Pharmaceutical Society of Ireland here today to assist in the Committee s on-going scrutiny of the Cannabis for Medicinal

More information

Standards for Professional Conduct In The Practice of Dentistry

Standards for Professional Conduct In The Practice of Dentistry Standards for Professional Conduct In The Practice of Dentistry Preamble The Standards for Professional Conduct for licensees of the Virginia Board of Dentistry establishes a set of principles to govern

More information

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL. PHARMACEUTICAL COMMITTEE 21 October 2015

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL. PHARMACEUTICAL COMMITTEE 21 October 2015 EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL Health systems and products Medicinal products authorisations, European Medicines Agency PHARM 689 PHARMACEUTICAL COMMITTEE 21 October 2015

More information

Review of Controlled Drugs and Substances Act

Review of Controlled Drugs and Substances Act Review of Controlled Drugs and Substances Act Canadian Medical Association: Submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations A

More information

Lobbyist-in-a-Box: (VPhAT) created on 01/15 at 10:11

Lobbyist-in-a-Box: (VPhAT) created on 01/15 at 10:11 Lobbyist-in-a-Box: (VPhAT) created on 01/15 at 10:11 HB 132 Controlled substances containing opioids; limits on prescription. Chief patron: Bell, John J. Limits on prescription of controlled substances

More information

EDICT ON PROMULGATION OF THE TOBACCO LAW TOBACCO LAW

EDICT ON PROMULGATION OF THE TOBACCO LAW TOBACCO LAW "Official Gazette of the Republic of Montenegro", Nos. 80/2004, 5/2005 By virtue of Article 88 item 2 of the Constitution of the Republic of Montenegro, I herewith enact this EDICT ON PROMULGATION OF THE

More information

Application to use Nutrition Australia Intellectual Property

Application to use Nutrition Australia Intellectual Property Application to use Nutrition Australia Intellectual Property All individuals, publishers and organisations must apply in writing to the Victorian Division for permission to use Nutrition Australia s Intellectual

More information

Submission to the Senate Community Affairs Legislation Committee inquiry into the Therapeutic Goods Amendment (2016 Measures No.

Submission to the Senate Community Affairs Legislation Committee inquiry into the Therapeutic Goods Amendment (2016 Measures No. Submission to the Senate Community Affairs Legislation Committee inquiry into the Therapeutic Goods Amendment (2016 Measures No. 1) Bill 2016 Submitted by: Submitted electronically to: Complementary Medicines

More information

MEMORANDUM OF UNDERSTANDING

MEMORANDUM OF UNDERSTANDING MEMORANDUM OF UNDERSTANDING BETWEEN THE NATIONAL ENERGY BOARD AND THE NORTHERN PIPELINE AGENCY CONCERNING THE PROVISION OF TECHNICAL ADVICE WITH RESPECT TO ENERGY MATTERS PREAMBLE WHEREAS the National

More information

Conflict of Interest Policy

Conflict of Interest Policy Revised 10/13/2016 Conflict of Interest Policy All AMIA leaders have an obligation to make decisions and conduct affairs of the organization based, first and foremost, upon the desire to promote AMIA and

More information

IT and Information Acceptable Use Policy

IT and Information Acceptable Use Policy BMI IMpol04 Information Management IT and Information Acceptable Use Policy This is a controlled document and whilst this document may be printed, the electronic version posted on the intranet/shared drive

More information

Medical Devices. BARBADOS Clarke Gittens Farmer

Medical Devices. BARBADOS Clarke Gittens Farmer Medical Devices BARBADOS Clarke Gittens Farmer CONTACT INFORMATION Danielle Maycock Clarke Gittens Farmer Parker House, Wildey Business Park Wildey Road, St. Michael, Barbados Tel. 246.436.6287 rsm@clarkes.com.bb

More information

Submission to the Misuse of Drugs Amendment Bill September Society and its Role and Functions. 29 September 2010

Submission to the Misuse of Drugs Amendment Bill September Society and its Role and Functions. 29 September 2010 PHARMACY HOUSE 124 DIXON STREET PO BOX 11 640 WELLINGTON NEW ZEALAND TELEPHONE 04 802 0030 FAX 04 382 9297 EMAIL p.society@psnz.org.nz WEBSITE www.psnz.org.nz 29 September 2010 Clerk of the Health Committee

More information

The Chartered Society of Physiotherapy Complaints Procedure

The Chartered Society of Physiotherapy Complaints Procedure 14 Bedford Row, London WC1R 4ED Tel +44 (0)20 7306 6666 Web www.csp.org.uk The Chartered Society of Physiotherapy Complaints Procedure issuing function Chief Executives Office date of issue May 2009 The

More information

THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL INTRODUCED BY DINNIMAN, FONTANA, SCHWANK, GREENLEAF, WARD AND FARNESE, APRIL 6, 2017

THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL INTRODUCED BY DINNIMAN, FONTANA, SCHWANK, GREENLEAF, WARD AND FARNESE, APRIL 6, 2017 PRIOR PRINTER'S NO. 0 PRINTER'S NO. THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL No. Session of 0 INTRODUCED BY DINNIMAN, FONTANA, SCHWANK, GREENLEAF, WARD AND FARNESE, APRIL, 0 SENATOR BAKER, HEALTH

More information

XOSERVE LIMITED SERVICES SCHEDULE FOR THE PROVISION OF NON-CODE USER PAYS SERVICES (REFERENCE NUMBER XNCUP(SS)06) DATED 20 INTRODUCTION

XOSERVE LIMITED SERVICES SCHEDULE FOR THE PROVISION OF NON-CODE USER PAYS SERVICES (REFERENCE NUMBER XNCUP(SS)06) DATED 20 INTRODUCTION XOSERVE LIMITED SERVICES SCHEDULE FOR THE PROVISION OF NON-CODE USER PAYS SERVICES (REFERENCE NUMBER XNCUP(SS)06) DATED 20 INTRODUCTION 1 This services schedule forms part of the framework contract for

More information

UNOFFICIAL COPY OF SENATE BILL 735 CHAPTER

UNOFFICIAL COPY OF SENATE BILL 735 CHAPTER UNOFFICIAL COPY OF SENATE BILL 735 E4 5lr1315 By: Senator Grosfeld Introduced and read first time: February 4, 2005 Assigned to: Judicial Proceedings Reassigned to: Education, Health, and Environmental

More information

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT c t DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to September 22, 2014. It is intended

More information

Medical Devices and Active Implantable Medical Devices

Medical Devices and Active Implantable Medical Devices Medical Devices and Active Implantable Medical Devices Exclusion Interpretation Guide MD e IAMD ANREEE October 2016 This document aims to clarify in what circumstances certain equipment can be considered

More information

HISTORY, CAPACITY AND POSITION

HISTORY, CAPACITY AND POSITION HISTORY, CAPACITY AND POSITION A high level presentation for SAPRAA April 2017 History Founded in 1976, the HPA has efficiently supported, promoted and protected the CAMs industry for 40 years. The HPA

More information

Workplace Drug and Alcohol Policy

Workplace Drug and Alcohol Policy Workplace Drug and Alcohol Policy January 2017 This Drug and Alcohol Policy is intended for and includes but is not limited to all Students, Contractors and all others either directly or indirectly engaged

More information

This follows similar work previously conducted by Bureau Veritas for Nestlé S.A. in other global operations.

This follows similar work previously conducted by Bureau Veritas for Nestlé S.A. in other global operations. Nestlé S.A. Independent Assurance of Compliance with the Nestlé Policy and Instructions for Implementation of the WHO International Code of Marketing of Breastmilk Substitutes in Colombia (May 2016) Independent

More information

Tobacco Free Ireland Action Plan

Tobacco Free Ireland Action Plan Tobacco Free Ireland Action Plan Tobacco Free Ireland, the report of the Tobacco Policy Review Group, was endorsed by Government, and published in October 2013. It builds on existing tobacco control policies

More information

FINAL MAY 2017 Novo Nordisk Scandinavia AB Methodology Note - reporting year 2016 ( Methodology ) Preamble General Summary...

FINAL MAY 2017 Novo Nordisk Scandinavia AB Methodology Note - reporting year 2016 ( Methodology ) Preamble General Summary... Novo Nordisk Scandinavia AB Methodology Note - reporting year 2016 ( Methodology ) Table of contents Preamble... 1 1. General Summary... 2 2. and Definitions... 3 Preamble Novo Nordisk Scandinavia AB (Novo

More information

General Terms and Conditions

General Terms and Conditions General Terms and Conditions Revision history (July 2008) Date issued Replaced pages Effective date 07/08 all pages 07/08 11/07 ii, iii, 2, 4 11/07 11/06 all pages 11/06 01/06 all pages 01/06 02/05 ii,

More information

INOVIO PHARMACEUTICALS, INC. INVESTIGATOR CONFLICT OF INTEREST POLICY

INOVIO PHARMACEUTICALS, INC. INVESTIGATOR CONFLICT OF INTEREST POLICY INOVIO PHARMACEUTICALS, INC. INVESTIGATOR CONFLICT OF INTEREST POLICY August 24, 2012 1. Purpose Public confidence and the reputation of the company are valuable business assets that Inovio strives to

More information

Title 32: PROFESSIONS AND OCCUPATIONS

Title 32: PROFESSIONS AND OCCUPATIONS Title 32: PROFESSIONS AND OCCUPATIONS Chapter 45-A: PHYSICAL THERAPIST PRACTICE ACT Table of Contents Section 3111. DEFINITIONS... 3 Section 3111-A. SCOPE OF PRACTICE... 3 Section 3112. BOARD CREATED;

More information

RULES. on Selection and Sale of Tobacco and Trade Terms with Suppliers CHAPTER I

RULES. on Selection and Sale of Tobacco and Trade Terms with Suppliers CHAPTER I RULES on Selection and Sale of Tobacco and Trade Terms with Suppliers CHAPTER I Article 1 Purpose The purpose of these Rules is to define and explain the product choices of the State Alcohol and Tobacco

More information

Guideline on the Regulation of Therapeutic Products in New Zealand

Guideline on the Regulation of Therapeutic Products in New Zealand Guideline on the Regulation of Therapeutic Products in New Zealand Part 10: Requirements for information for prescribers and consumers Edition 7.0 January 2016 Section 1: Legislation Section summary This

More information

COMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES

COMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES COMPETENT AUTHORITY (UK) 10 EC MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES (CUSTOM MADE DEVICES) Updated March 2008 CONTENTS PAGE Introduction 3 Definition of dental

More information

Acceptable Use Policy - Phone

Acceptable Use Policy - Phone These terms are current as of August 5, 2017 and are subject to change from time to time. Please visit shaw.ca for the most current Terms of Use. Acceptable Use Policy - Phone Introduction Thank you for

More information

Recall Guidelines. for Chinese Medicine Products

Recall Guidelines. for Chinese Medicine Products Recall Guidelines for Chinese Medicine Products April 2018 Recall Guidelines for Chinese Medicine Products Chinese Medicines Board Chinese Medicine Council of Hong Kong Compiled in September 2005 1 st

More information

Independent Assurance Statement by Bureau Veritas

Independent Assurance Statement by Bureau Veritas Nestlé S.A. Independent Assurance of Compliance with the Nestlé Policy and Instructions for Implementation of the WHO International Code of Marketing of Breastmilk Substitutes in Kenya (May 2014) Independent

More information

Medical Devices Act 1

Medical Devices Act 1 Issuer: Riigikogu Type: act In force from: 01.01.2016 In force until: 31.05.2016 Translation published: 01.02.2016 Medical Devices Act 1 Amended by the following acts Passed 13.10.2004 RT I 2004, 75, 520

More information

The Dental Therapists (General) Regulations

The Dental Therapists (General) Regulations DENTAL THERAPISTS (GENERAL) D-6.1 REG 2 1 The Dental Therapists (General) Regulations Repealed by Saskatchewan Regulations 40/98 (effective May 13, 1998). Formerly Chapter D-6.1 Reg 2 (effective July 1,

More information

FORM 223 GOVERNMENT NOTICE

FORM 223 GOVERNMENT NOTICE No. 29079 GOVERNMENT GAZETTE, 4 AUGUST 2006 FORM 223 GOVERNMENT NOTICE DEPARTMENT OF HEALTH No. R. 717 04 AUGUST 2006 HEALTH PROFESSIONS ACT, 1974 (ACT NO. 56 OF 1974) ETHICAL RULES OF CONDUCT FOR PRACTITIONERS

More information

SADAG submission to the Competition Commission: Market Inquiry into the Private Healthcare Sector

SADAG submission to the Competition Commission: Market Inquiry into the Private Healthcare Sector THE SOUTH AFRICAN DEPRESSION AND ANXIETY GROUP NPO 013-085 Reg. No. 2000/025903/08 P O Box 652548 Benmore 2010 Tel: +27 11 234 4870 Fax: +27 11 234 8182 office@anxiety.org.za www.sadag.org SADAG submission

More information

Access to electronic communications services for disabled customers

Access to electronic communications services for disabled customers Access to electronic communications services for disabled customers Statement Publication date: 12 March 2014 Contents Section Page 1 Summary 1 2 Introduction 2 3 Access to and pricing of the relay service

More information

NEWS. Speech Language & Hearing Professions. Chairperson s Note. HPCSA online renewal and payment portal

NEWS. Speech Language & Hearing Professions. Chairperson s Note. HPCSA online renewal and payment portal Speech Language & Issue 01/11/2017 November 2017 SLH NEWS 1 Health Professions Council of South Africa Hearing Professions NEWS Newsletter for Speech Language and Hearing Professions (SLH) Board Chairperson

More information

REGULATION (EC) No.141/2000

REGULATION (EC) No.141/2000 REGULATION (EC) No.141/2000 Community legislation in force Document 300R0141 Directory chapters where this document can be found: [15.30 Health promotion] Regulation (EC) No.141/2000 of the European Parliament

More information

Health (Tobacco, Nicotine etc. and Care)(Scotland) Bill. Japan Tobacco International (JTI)

Health (Tobacco, Nicotine etc. and Care)(Scotland) Bill. Japan Tobacco International (JTI) Health (Tobacco, Nicotine etc. and Care)(Scotland) Bill Organisation name Japan Tobacco International (JTI) Japan Tobacco International (JTI) is part of the Japan Tobacco group (JT Group) of companies,

More information

AN ACT. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:

AN ACT. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Pennsylvania General Assembly http://www.legis.state.pa.us/cfdocs/legis/li/uconscheck.cfm?txttype=htm&yr=2014&sessind=0&smthlwind=0&act=89 07/17/2014 12:54 PM Home / Statutes of Pennsylvania / Unconsolidated

More information

Draft Guidelines on the Sale and Supply of Non- Prescription Medicinal Products from a Retail Pharmacy Business

Draft Guidelines on the Sale and Supply of Non- Prescription Medicinal Products from a Retail Pharmacy Business Draft Guidelines on the Sale and Supply of Non- Prescription Medicinal Products from a Retail Pharmacy Business To facilitate compliance with Regulations 5(1)(d), 5(1)(h) and 10 of the Regulation of Retail

More information

Alcohol, Tobacco and Other Drugs Minimum Standard. April 2015

Alcohol, Tobacco and Other Drugs Minimum Standard. April 2015 Alcohol, Tobacco and Other Drugs Minimum Standard April 2015 Contents 1 Executive Summary... 2 2 More Information... 2 3 Using this Standard... 2 4 Standard Provisions... 2 4.1 Legislative Requirements...

More information

ORDINANCE NO

ORDINANCE NO ORDINANCE NO. 01-2017 AN ORDINANCE OF THE CITY COUNCIL OF THE CITY OF SEMINOLE, FLORIDA, REGARDING MEDICAL CANNABIS; IMPOSING A TEMPORARY MORATORIUM ON THE SALE OF MEDICAL CANNABIS AND ON THE ESTABLISHMENT

More information

We get your personal data from the following sources (examples detailed below are not exhaustive):

We get your personal data from the following sources (examples detailed below are not exhaustive): Novo Nordisk Limited processes (e.g. collects, uses, stores, and shares) personal data for different reasons (purpose) and uses a number of legal bases to process that personal data. This Notice explains

More information

Response to Scottish Government A Consultation on Electronic Cigarettes and Strengthening Tobacco Control in Scotland December 2014

Response to Scottish Government A Consultation on Electronic Cigarettes and Strengthening Tobacco Control in Scotland December 2014 Responseto ScottishGovernment AConsultationonElectronicCigarettesand StrengtheningTobaccoControlinScotland December2014 Contact Janice Oman Scotland Representation Manager National Pharmacy Association

More information

ALCOHOL ETC. (SCOTLAND) ACT 2010 GUIDANCE FOR LICENSING BOARDS

ALCOHOL ETC. (SCOTLAND) ACT 2010 GUIDANCE FOR LICENSING BOARDS ALCOHOL ETC. (SCOTLAND) ACT 2010 GUIDANCE FOR LICENSING BOARDS August 2011 1 ALCOHOL ETC. (SCOTLAND) ACT 2010 GUIDANCE FOR BOARDS AND LOCAL AUTHORITIES CONTENTS LIST 1. Introduction 2. Pricing of alcohol

More information

NEW YORK STATE MEDICAID PROGRAM HEARING AID/AUDIOLOGY MANUAL

NEW YORK STATE MEDICAID PROGRAM HEARING AID/AUDIOLOGY MANUAL NEW YORK STATE MEDICAID PROGRAM HEARING AID/AUDIOLOGY MANUAL POLICY GUIDELINES Table of Contents SECTION I - REQUIREMENTS FOR PARTICIPATION IN MEDICAID...2 SERVICES PROVIDED TO PATIENTS UNDER 21 YEARS

More information

ANNEXURE A SUPPLIER DECLARATION FORM P a g e

ANNEXURE A SUPPLIER DECLARATION FORM P a g e ANNEXURE A SUPPLIER DECLARATION FORM - 1 - P a g e Health Professions Council of South Africa This form must be completed and submitted with TENDER: Health Professions Council of South Africa P O Box 205

More information

Regulations. On Proper Conduct in Research TEL AVIV UNIVERSITY

Regulations. On Proper Conduct in Research TEL AVIV UNIVERSITY Regulations On Proper Conduct in Research TEL AVIV UNIVERSITY 1. Preamble: Tel Aviv University aspires to excellence in research. Excellence is not gauged solely according to research results. It depends

More information

Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients

Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients Pharmaceutical Society of Ireland Version 3 October 2017 Updates made following the enactment

More information

For An Act To Be Entitled. Subtitle

For An Act To Be Entitled. Subtitle 0 0 State of Arkansas INTERIM STUDY PROPOSAL 0-0th General Assembly A Bill DRAFT JMB/JMB Second Extraordinary Session, 0 SENATE BILL By: Senator J. Hutchinson Filed with: Arkansas Legislative Council pursuant

More information

2018 Business Associate Sponsorship Options

2018 Business Associate Sponsorship Options 2018 Business Associate Sponsorship Options P.O. Box 790 - Sherwood, OR 97140 Phone (678) 523-5915 - Fax (877) 872-3493 - Email: main@ohiomgma.com - www.ohiomgma.com members are healthcare leaders and

More information

Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016

Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016 Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016 To whom it may concern, Thank you for the opportunity to submit on the Draft Public Health (Tobacco) Regulations 2016

More information

PROSPECTUS FOR SPONSORS

PROSPECTUS FOR SPONSORS 17th Annual Health Care Symposium Living the Mission Achieving the Vision PROSPECTUS FOR SPONSORS Hosted by: Coalition of Orange County Community Health Centers Community Clinic Association of Los Angeles

More information

Return Date: February 27, 2002

Return Date: February 27, 2002 Return Date: February 27, 2002 Time: 9:30 a.m. COUCH WHITE, LLP 540 Broadway P.O. Box 22222 Albany, New York 12201-2222 (518) 426-4600 Harold N. Iselin, Esq. (H.I. 1428) James J. Barriere, Esq. (J.B. 3206)

More information

KENTUCKY COMMUNITY AND TECHNICAL COLLEGE SYSTEM BUSINESS PROCEDURES MANUAL

KENTUCKY COMMUNITY AND TECHNICAL COLLEGE SYSTEM BUSINESS PROCEDURES MANUAL Effective: January 1, 2015 Page 1 of 5 Alcoholic Beverage Use on KCTCS Facilities Section 4.20.1 -General Section 4.20.2- Approved Locations, Functions, and Forms Section 4.20.3 - Required Licenses Section

More information

COMPLETE DRUG AND ALCOHOL POLICY & Testing Policy

COMPLETE DRUG AND ALCOHOL POLICY & Testing Policy COMPLETE DRUG AND ALCOHOL POLICY & Testing Policy... Rev 12/2012 1 I. STATEMENT OF POLICY Robért Resources LLC. ( Robért s ) and it s related companies is committed to providing safe, healthful, and efficient

More information

National Health Reference Price List: Draft changes for Version 2.06

National Health Reference Price List: Draft changes for Version 2.06 Private Bag X34, HATFIELD, 0028 Hadefields Block E, 1267 Pretorius Street, HATFIELD Phone: +27 (0) 12 431-0500 Fax: +27 (0) 12 430-7644 Http://www.medicalschemes.com To: All medical schemes, administrators,

More information

PROPOSED REGULATION OF THE BOARD OF HEARING AID SPECIALISTS. LCB File No. R July 6, 2001

PROPOSED REGULATION OF THE BOARD OF HEARING AID SPECIALISTS. LCB File No. R July 6, 2001 PROPOSED REGULATION OF THE BOARD OF HEARING AID SPECIALISTS LCB File No. R062-01 July 6, 2001 EXPLANATION Matter in italics is new; matter in brackets [omitted material] is material to be omitted. AUTHORITY:

More information

PURPOSE SCOPE BACKGROUND COLLEGE OF RESPIRATORY THERAPISTS OF ONTARIO

PURPOSE SCOPE BACKGROUND COLLEGE OF RESPIRATORY THERAPISTS OF ONTARIO COLLEGE OF RESPIRATORY THERAPISTS OF ONTARIO Title: Funding for Supportive Measures (Patient/Client) Date originally approved: September 21, 2018 Number: PR-Funding-103 Date(s) revision approved: N/A PURPOSE

More information